The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
The best Bull and Bear pitches based on recency and number of recommendations.
Very rich valuation + unimpressive pipeline + stock went up (???) following 13-1 thrashing of ridaforolimus as maintenance therapy for patients with mSTS by ODAC.
Read the most recent pitches from players about ARIA.DL.
Find the members with the highest scoring picks in ARIA.DL.
See what the Wall Street professionals think, according to their public statements and filings.